373 related articles for article (PubMed ID: 20937370)
1. Development of biodegradable porous starch foam for improving oral delivery of poorly water soluble drugs.
Wu C; Wang Z; Zhi Z; Jiang T; Zhang J; Wang S
Int J Pharm; 2011 Jan; 403(1-2):162-9. PubMed ID: 20937370
[TBL] [Abstract][Full Text] [Related]
2. Biodegradable Porous Starch Spheres as a Novel Carrier for Enhancement of Dissolution Rate and Oral Bioavailability of Itraconazole.
Pawar J; Ali MT; Fule R; Moravkar K; Seervi M; Sathaye S; Amin P
Curr Drug Deliv; 2017; 14(7):944-954. PubMed ID: 27654575
[TBL] [Abstract][Full Text] [Related]
3. Oxidized mesoporous silicon microparticles for improved oral delivery of poorly soluble drugs.
Wang F; Hui H; Barnes TJ; Barnett C; Prestidge CA
Mol Pharm; 2010 Feb; 7(1):227-36. PubMed ID: 19874003
[TBL] [Abstract][Full Text] [Related]
4. Preparation of novel porous starch microsphere foam for loading and release of poorly water soluble drug.
Jiang T; Wu C; Gao Y; Zhu W; Wan L; Wang Z; Wang S
Drug Dev Ind Pharm; 2014 Feb; 40(2):252-9. PubMed ID: 23391363
[TBL] [Abstract][Full Text] [Related]
5. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
[TBL] [Abstract][Full Text] [Related]
6. Carboxylated mesoporous carbon microparticles as new approach to improve the oral bioavailability of poorly water-soluble carvedilol.
Zhang Y; Zhi Z; Li X; Gao J; Song Y
Int J Pharm; 2013 Sep; 454(1):403-11. PubMed ID: 23850816
[TBL] [Abstract][Full Text] [Related]
7. Exploitation of 3D face-centered cubic mesoporous silica as a carrier for a poorly water soluble drug: influence of pore size on release rate.
Zhu W; Wan L; Zhang C; Gao Y; Zheng X; Jiang T; Wang S
Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():78-85. PubMed ID: 24268236
[TBL] [Abstract][Full Text] [Related]
8. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels.
Zahedi P; Lee PI
Eur J Pharm Biopharm; 2007 Mar; 65(3):320-8. PubMed ID: 17182231
[TBL] [Abstract][Full Text] [Related]
9. Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery.
Jug M; Maestrelli F; Bragagni M; Mura P
J Pharm Biomed Anal; 2010 May; 52(1):9-18. PubMed ID: 20004541
[TBL] [Abstract][Full Text] [Related]
10. To enhance dissolution rate of poorly water-soluble drugs: glucosamine hydrochloride as a potential carrier in solid dispersion formulations.
Al-Hamidi H; Edwards AA; Mohammad MA; Nokhodchi A
Colloids Surf B Biointerfaces; 2010 Mar; 76(1):170-8. PubMed ID: 19945828
[TBL] [Abstract][Full Text] [Related]
11. Novel valsartan-loaded solid dispersion with enhanced bioavailability and no crystalline changes.
Yan YD; Sung JH; Kim KK; Kim DW; Kim JO; Lee BJ; Yong CS; Choi HG
Int J Pharm; 2012 Jan; 422(1-2):202-10. PubMed ID: 22085435
[TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability.
Zhuang CY; Li N; Wang M; Zhang XN; Pan WS; Peng JJ; Pan YS; Tang X
Int J Pharm; 2010 Jul; 394(1-2):179-85. PubMed ID: 20471464
[TBL] [Abstract][Full Text] [Related]
13. Development of novel itraconazole-loaded solid dispersion without crystalline change with improved bioavailability.
Park YJ; Xuan JJ; Oh DH; Balakrishnan P; Yang HJ; Yeo WH; Lee MK; Choi HG; Yong CS
Arch Pharm Res; 2010 Aug; 33(8):1217-25. PubMed ID: 20803125
[TBL] [Abstract][Full Text] [Related]
14. Preparation of starch macrocellular foam for increasing the dissolution rate of poorly water-soluble drugs.
Zhao Y; Wu C; Zhao Z; Hao Y; Xu J; Yu T; Qiu Y; Jiang J
Pharm Dev Technol; 2016 Sep; 21(6):749-54. PubMed ID: 26166407
[TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of pH-independent sustained release tablet containing solid dispersion granules of a poorly water-soluble drug.
Tran HT; Park JB; Hong KH; Choi HG; Han HK; Lee J; Oh KT; Lee BJ
Int J Pharm; 2011 Aug; 415(1-2):83-8. PubMed ID: 21641985
[TBL] [Abstract][Full Text] [Related]
16. Controlled poorly soluble drug release from solid self-microemulsifying formulations with high viscosity hydroxypropylmethylcellulose.
Yi T; Wan J; Xu H; Yang X
Eur J Pharm Sci; 2008 Aug; 34(4-5):274-80. PubMed ID: 18541418
[TBL] [Abstract][Full Text] [Related]
17. Low density porous carrier drug adsorption and release study by response surface methodology using different solvents.
Sher P; Ingavle G; Ponrathnam S; Pawar AP
Int J Pharm; 2007 Feb; 331(1):72-83. PubMed ID: 17030470
[TBL] [Abstract][Full Text] [Related]
18. Poloxamer 407 microspheres for orotransmucosal drug delivery. Part I: formulation, manufacturing and characterization.
Albertini B; Passerini N; Di Sabatino M; Monti D; Burgalassi S; Chetoni P; Rodriguez L
Int J Pharm; 2010 Oct; 399(1-2):71-9. PubMed ID: 20696227
[TBL] [Abstract][Full Text] [Related]
19. Preparation of a novel starch-derived three-dimensional ordered macroporous carbon for improving the dissolution rate and oral bioavailability of water-insoluble drugs.
Liu Y; Wu C; Hao Y; Xu J; Zhao Y; Qiu Y; Jiang J; Yu T; Ji P
J Pharm Biomed Anal; 2016 Jan; 118():267-275. PubMed ID: 26580824
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of dissolution rate and oral absorption of a poorly water-soluble drug, K-832, by adsorption onto porous silica using supercritical carbon dioxide.
Miura H; Kanebako M; Shirai H; Nakao H; Inagi T; Terada K
Eur J Pharm Biopharm; 2010 Oct; 76(2):215-21. PubMed ID: 20603215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
